About
Stanford Peng is a Venture Partner at Frazier Life Sciences, where he works on company creation, joining the firm in 2025. A physician-scientist and R&D executive with over 25 years of drug development and biomedical research experience, he most recently served as President and Head of R&D at Alpine Immune Sciences, which was acquired by Vertex Pharmaceuticals. He has previously held roles at Stemcentrx, Seagen, Roche, Benaroya Research Institute, and Washington University in St. Louis, and continues to practice as a rheumatologist.
Invests in
Biotech
Experience
- Frazier Life SciencesVenture Partnercurrent2025 — present
- Alpine Immune Sciences (acquired by Vertex Pharmaceuticals)President and Head of Research & Development2016 — 2024
- Stemcentrx, Inc. (acquired by Abbvie)Chief Medical Officer2015 — 2016
Education
- Brigham and Women's HospitalFellowship, Rheumatology
- University of Pennsylvania School of MedicineResidency, Internal Medicine
- Yale School of MedicineMD, PhD
- Stanford UniversityBA, BS
Skills & more
Lifesciences15Rheumatology31Biomarkers11Immunology53Biotechnology54Clinical Development51Clinical Research70Drug Discovery6Clinical Trials25Molecular Biology8Oncology10Drug Development11
+12 more
Translational ResearchCancerMedicineInfectious DiseasesPharmacologyVirologyMedical WritingNeurosciencePharmaceutical IndustryTeam LeadershipTranslational MedicineBiostatistics- Registered in Musculoskeletal (RMSK) Sonography — American Registry for Diagnostic Medical Sonography
- Internal Medicine — American Board of Internal Medicine
- Rheumatology — American Board of Internal Medicine
- Physician — Medical Board of California
- Physician — Washington State Department of Health
From Stanford's professional profile.
Same school
Also attended University of Pennsylvania School of Medicine23
Jun JeonInvestor at Khosla VenturesSeth GlickmanDigital Health Advisor at Excelerate Health VenturesJonathan LeffExecutive Partner, Private Equity at Sofinnova VenturesFrederick JonesAdvisory Partner at BioAdvanceRené KuijtenPartner, Head of EQT Life Sciences at EQT Life SciencesAaron NelsonManaging Director at Novartis Venture Fund
+ 17 more
Also attended Yale School of Medicine23
Lars PedersenPartner, Chief Financial Officer at Redpoint VenturesAlexi Nazem, MDGeneral Partner at AlleyCorpBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalMax FarinaPrincipal at 5AM VenturesBrian YordyPrincipal at F-Prime Capital PartnersStephen KnightPresident & Senior Managing Partner at F-Prime Capital Partners
+ 17 more
Also attended Stanford University1,726
Peter ThielCo-founder & Partner at Founders FundReid HoffmanCo-founder of LinkedIn; Partner at GreylockDavid SacksCo-founder & General Partner at Craft Ventures; former White House AI & Crypto CzarKeith RaboisManaging Director at Khosla VenturesGarry TanPresident & CEO of Y CombinatorAlfred LinPartner at Sequoia Capital
+ 1,720 more
Shared employers
Also worked at Frazier Life Sciences46
Patrick HeronManaging Partner at Frazier Life SciencesDaniel EstesGeneral Partner at Frazier Life SciencesJames W. BrushGeneral Partner and Portfolio Manager at Frazier Life SciencesAnna H. ChenPartner at Frazier Life SciencesGordon EmpeyCOO, Partner and General Counsel at Frazier Life SciencesKevin LiPrincipal at Frazier Life Sciences
+ 40 more
Colleagues at Frazier Life Sciences
Adam Simpson
Venture Partner at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Alan Frazier
Chairman Emeritus at Frazier Life Sciences
Albert Cha
Managing Partner at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences